Clinical trial
A Prospective, Multi-center, Investigator Sponsored, Randomized Controlled Trial-- The Prophylactic Effect of Stilamin on Post-ERCP Pancreatitis
NCT01431781 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center, Investigator Sponsored, Randomized Controlled Trial-- The Prophylactic Effect of Stilamin on Post-ERCP Pancreatitis
- Lead sponsor
- Changhai Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2011
- Completion date
- March 31, 2013
- Enrollment
- 908 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
post-ercp acute pancreatitis